Immunocore Limited
Private Limited Company · Abingdon
ActiveUnited KingdomIncorporated 2007Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No processed account filings
No processed accounts are available in our records.
Registered details
06456207- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2007-12-18
- Jurisdiction
- —
- Registered office
- 92, PARK DRIVE, ABINGDON, OXFORDSHIRE, OX14 4RY, UNITED KINGDOM
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
19 matched grantsTowards new biologic drugs: In silico design of T-cell receptor affinity and specificity with biomolecular simulationActiveBBSRC · Studentship · 2024-09-30 – 2028-09-29 · with 1 other participant£0whole project
Towards new biologic drugs: In silico design of T-cell receptor affinity and specificity with biomolecular simulationActive
BBSRC · Studentship · 2024-09-30 – 2028-09-29 · with 1 other participant
£0
whole project
University of BristolleadImmunocore Ltd
Developing a pre-clinical human pancreatic cancer model to test novel immunotherapies.ActiveMRC · Studentship · 2024-09-30 – 2028-09-29 · with 1 other participant£0whole project
Developing a pre-clinical human pancreatic cancer model to test novel immunotherapies.Active
MRC · Studentship · 2024-09-30 – 2028-09-29 · with 1 other participant
£0
whole project
King'S College LondonleadImmunocore Ltd
Exploring gamma delta T cell immunosurveillance in ovarian cancerActiveMRC · Studentship · 2024-09-29 – 2028-09-29 · with 1 other participant£0whole project
Exploring gamma delta T cell immunosurveillance in ovarian cancerActive
MRC · Studentship · 2024-09-29 – 2028-09-29 · with 1 other participant
£0
whole project
University of WarwickleadImmunocore Ltd
Controlling protein self-assembly and stability using biological ionsActiveBBSRC · Studentship · 2022-09-30 – 2026-09-29 · with 1 other participant£0whole project
Controlling protein self-assembly and stability using biological ionsActive
BBSRC · Studentship · 2022-09-30 – 2026-09-29 · with 1 other participant
£0
whole project
University Of ManchesterleadImmunocore Ltd
Using Nanotechnology to address antibiotic resistanceEPSRC · Studentship · 2021-10-03 – 2025-10-02 · with 1 other participant£0whole project
Using Nanotechnology to address antibiotic resistance
EPSRC · Studentship · 2021-10-03 – 2025-10-02 · with 1 other participant
£0
whole project
University Of BirminghamleadImmunocore Ltd
Identification and characterisation of novel ligands presented by the Major Histocompatibility Complex class I-related gene protein (MR1)BBSRC · Studentship · 2021-10-03 – 2025-10-02 · with 1 other participant£0whole project
Identification and characterisation of novel ligands presented by the Major Histocompatibility Complex class I-related gene protein (MR1)
BBSRC · Studentship · 2021-10-03 – 2025-10-02 · with 1 other participant
£0
whole project
University Of BirminghamleadImmunocore Ltd
Bioinformatics tools for T-cell receptor based drugsMRC · Studentship · 2021-09-30 – 2025-08-30 · with 1 other participant£0whole project
Bioinformatics tools for T-cell receptor based drugs
MRC · Studentship · 2021-09-30 – 2025-08-30 · with 1 other participant
£0
whole project
University College LondonleadImmunocore Ltd
Predicting TCR structures and binding in-silicoEPSRC · Studentship · 2021-09-30 – 2025-12-31 · with 1 other participant£0whole project
Predicting TCR structures and binding in-silico
EPSRC · Studentship · 2021-09-30 – 2025-12-31 · with 1 other participant
£0
whole project
University Of OxfordleadImmunocore Ltd
Physico-chemical aspects of formulating next generation biologics, including TCRs (T cell receptors).EPSRC · Studentship · 2020-12-01 – 2024-05-30 · with 1 other participant£0whole project
Physico-chemical aspects of formulating next generation biologics, including TCRs (T cell receptors).
EPSRC · Studentship · 2020-12-01 – 2024-05-30 · with 1 other participant
£0
whole project
University of BristolleadImmunocore Ltd
Standardised metabolite annotation workflows for enhanced biological interpretation in metabolomic data repositoriesBBSRC · Research Grant · 2020-03-31 – 2021-10-29 · with 2 other participants£572,064whole project
Standardised metabolite annotation workflows for enhanced biological interpretation in metabolomic data repositories
BBSRC · Research Grant · 2020-03-31 – 2021-10-29 · with 2 other participants
£572,064
whole project
University Of BirminghamleadImmunocore LtdImperial College London
MICA Investigating CD1c lipid-antigen presentation and its role in tuberculosisMRC · Research Grant · 2019-08-31 – 2025-08-30 · with 3 other participants£879,506whole project
MICA Investigating CD1c lipid-antigen presentation and its role in tuberculosis
MRC · Research Grant · 2019-08-31 – 2025-08-30 · with 3 other participants
£879,506
whole project
University of SouthamptonleadImmunocore LtdK-RITH (KwaZulu-Natal Research Inst)The Francis Crick Institute
Investigating CD1c Lipid-antigen presentation and its role in tuberculosisMRC · Studentship · 2019-01-07 – 2022-09-29 · with 1 other participant£0whole project
Investigating CD1c Lipid-antigen presentation and its role in tuberculosis
MRC · Studentship · 2019-01-07 – 2022-09-29 · with 1 other participant
£0
whole project
University of SouthamptonleadImmunocore Ltd
Unconventional aspects of MR1 restricted T-cellsMRC · Studentship · 2018-09-30 – 2022-09-29 · with 1 other participant£0whole project
Unconventional aspects of MR1 restricted T-cells
MRC · Studentship · 2018-09-30 – 2022-09-29 · with 1 other participant
£0
whole project
University Of OxfordleadImmunocore Ltd
Enabling rapid liquid and freeze-dried formulation design for the manufacture and delivery of novel biopharmaceuticalsEPSRC · Research Grant · 2016-07-21 – 2022-11-30 · with 3 other participants£861,317whole project
Enabling rapid liquid and freeze-dried formulation design for the manufacture and delivery of novel biopharmaceuticals
EPSRC · Research Grant · 2016-07-21 – 2022-11-30 · with 3 other participants
£861,317
whole project
Enabling rapid liquid and freeze-dried formulation design for the manufacture and delivery of novel biopharmaceuticalsEPSRC · Research Grant · 2016-06-30 – 2022-01-31 · with 14 other participants£1,519,555whole project
Enabling rapid liquid and freeze-dried formulation design for the manufacture and delivery of novel biopharmaceuticals
EPSRC · Research Grant · 2016-06-30 – 2022-01-31 · with 14 other participants
£1,519,555
whole project
University College LondonleadArecor LtdAstrazenecaBoehringer IngelheimCelltech Group plcFujifilm UK LtdGskImmunocore LtdIpsen Biopharmaceutical LtdLgc LtdMedicines & Healthcare pdts Reg Acy MHRANational Institute for Biological Standards and Control (NIBSC)Pall EuropeUcb SAWyatt Technology UK Ltd
Multi-scale enzyme modelling for SynBio: optimizing biocatalysts for selective synthesis of bioactive compoundsBBSRC · Fellowship · 2015-12-01 – 2021-05-30 · with 5 other participants£709,409whole project
Multi-scale enzyme modelling for SynBio: optimizing biocatalysts for selective synthesis of bioactive compounds
BBSRC · Fellowship · 2015-12-01 – 2021-05-30 · with 5 other participants
£709,409
whole project
University of BristolleadChain BiotechImmunocore LtdUniversity of BathUniversity of WaikatoWilfrid Laurier University
The UK High-End Computing Consortium for Biomolecular SimulationEPSRC · Research Grant · 2013-11-01 – 2019-01-31 · with 22 other participants£288,481whole project
The UK High-End Computing Consortium for Biomolecular Simulation
EPSRC · Research Grant · 2013-11-01 – 2019-01-31 · with 22 other participants
£288,481
whole project
University of BristolleadAutonomous University of Barcelona (UAB)Budapest University of Technology and EconomicsComplutense University of MadridEuropean Cooperation in Science and Technology (COST)EvotecEvotec (UK) LtdHeriot-Watt UniversityImmunocore LtdJohnson & JohnsonMarlow FoodsNovartisResearch Complex at HarwellSanofiToronto Metropolitan UniversityUbon Ratchathani UniversityUcb SAUniversity College DublinUniversity of BathUniversity of CambridgeUniversity Of EdinburghUniversity of WaikatoVertex Pharmaceuticals
Clinical development of a new targeted therapy for the treatment of prostate cancerLead
Innovate UK · Collaborative R&D · 2013-10-01 – 2016-09-30
£2,400,000
awarded
Systems approach to the analysis of T cell receptor signal transductionMRC · Research Grant · 2012-02-01 – 2015-01-31 · with 2 other participants£412,134whole project
Systems approach to the analysis of T cell receptor signal transduction
MRC · Research Grant · 2012-02-01 – 2015-01-31 · with 2 other participants
£412,134
whole project
University Of OxfordleadImmunocore LtdNational Institute of Health and Medical Research (INSERM)